Ownership history in Rhenman & Partners Asset Management AB Β· 14 quarters on record
This page tracks every 13F SEC filing in which Rhenman & Partners Asset Management AB reported a position in ALIGNMENT HEALTHCARE INC (ALHC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Rhenman & Partners Asset Management AB outperformed the S&P 500 by +42.9% annually on this ALHC position. Timing score: 25% (3/12 decisions correct). Average cost basis: $8.11. Maximum drawdown during holding period: β58.1%.
π₯ Exceptional β beat the S&P 500 by 42.9% per year on this position.
11 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
3 of 12 add/trim decisions correct
Best entry: $4.96 (2024 Q1) Β· Worst: $17.45 (2025 Q3)
πͺ Held through 2 major drawdowns (>20%).
7 adds Β· 6 trims. Bought during 3 of 6 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 1.86% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size